Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recurrent Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Chronic Myeloid Leukemia.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2017

Swansbury John

Abstract excerpt

The commonest types of myeloproliferative neoplasm (MPN) have remarkably similar recurrent chromosome abnormalities, but with varying incidence and prognostic implications. After a clear decade of treatment of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors, the differing prognostic implications of abnormalities additional to the Ph chromosome are being revealed. This chapter provides a description...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Genetic Association Studies
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Karyotyping

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Molecular Targeted Therapy

Share to Myeloproliferative Disorders

Share to Translocation, Genetic

Source

Identifiers

PMID: 27910028
DOI: 10.1007/978-1-4939-6703-2_20

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recurrent Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Chronic Myeloid Leukemia.PMID 27910028Read ↗

Cytogenetics and genomics in CML and other myeloproliferative neoplasms.Semantic proximity Read ↗

The role of cytogenetics and molecular biology in the diagnosis, treatment and monitoring of patients with chronic myeloid leukemiaSemantic proximity Read ↗

Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia.Semantic proximity Read ↗

Chronic myeloid leukemia: a type of MPNSemantic proximity Read ↗

Advances in molecular evaluation of myeloproliferative neoplasms.Semantic proximity Read ↗

Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approachesSemantic proximity Read ↗

Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs).Semantic proximity Read ↗

Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolutionSemantic proximity Read ↗

Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatmentSemantic proximity Read ↗

Genetic and epigenetic alterations of myeloproliferative disorders.Semantic proximity Read ↗

Genomics of Myeloproliferative Neoplasms.Semantic proximity Read ↗

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.